Companies /Healthcare

Abbvie Inc

NYSE: ABBV Drug Manufacturers - General
$264.34
▼ $0.78 (−0.29%) today
Markets closed · 1:16am ET

ABBV Coverage

Page 26
11:50am ET
Health and Healthcare

AbbVie Slides on Weak Midstage Results

AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small cell lung cancer trial.

Chris Lange